---
document_datetime: 2025-08-26 12:20:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/bosulif-epar-all-authorised-presentations_en.pdf
document_name: bosulif-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2818623
conversion_datetime: 2025-12-31 04:19:57.576486
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size    |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|--------------|
| EU/1/13/818/001  | Bosulif           | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/ PCTFE /PVC) | 28 tablets   |
| EU/1/13/818/002  | Bosulif           | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/ PCTFE /PVC) | 30 tablets   |
| EU/1/13/818/003  | Bosulif           | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/ PCTFE /PVC) | 28 tablets   |
| EU/1/13/818/004  | Bosulif           | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/ PCTFE /PVC) | 30 tablets   |
| EU/1/13/818/005  | Bosulif           | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/ PCTFE /PVC) | 112 tablets  |
| EU/1/13/818/006  | Bosulif           | 400 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PCTFE/PVC)   | 28 tablets   |
| EU/1/13/818/007  | Bosulif           | 400 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PCTFE/PVC)   | 30 tablets   |
| EU/1/13/818/008  | Bosulif           | 50 mg      | Capsule, hard         | Oral use                  | Bottle (HDPE)             | 30 capsules  |
| EU/1/13/818/009  | Bosulif           | 100 mg     | Capsule, hard         | Oral use                  | Bottle (HDPE)             | 150 capsules |